IT’S one thing to be sweating in the gym after a workout or on holiday when the sun is beating down.  But what about if you ...

Kenya's realtor Mwenda Thuranira, CEO of MySpace Properties, launched a natural deodorant inspired by his struggle with ...

The monsoon in India brings a refreshing respite from the heat, but it often brings a host of skin troubles too. The increased humidity, fluctuating temperatures, and dampness can throw your skin`s ...

Detailed price information for Dermata Therapeutics Inc (DRMA-Q) from The Globe and Mail including charting and trades.

The Company is also planning to initiate a Phase 2a study of DMT410 (XYNGARI with DAXXIFY®) for the treatment of axillary hyperhidrosis. About Dermata Therapeutics ...

The local share market has finished about where it began after gyrating between positive and negative territory before and after the Reserve Bank's surprise decision on interest rates.

The Company has successfully completed proof-of-concept Phase 1 clinical trials using DMT410 in combination with BOTOX® for the treatment of primary axillary hyperhidrosis and for the treatment ...

Treatment of hyperhidrosis can be divided into topical, oral, surgical, and nonsurgical treatments (botulinum toxin). These therapeutic options differ with respect to their efficacy, duration of ...